DE3785673D1 - Monoklonaler antikoerper spezifisch gegen neutrophilen. - Google Patents

Monoklonaler antikoerper spezifisch gegen neutrophilen.

Info

Publication number
DE3785673D1
DE3785673D1 DE8888900179T DE3785673T DE3785673D1 DE 3785673 D1 DE3785673 D1 DE 3785673D1 DE 8888900179 T DE8888900179 T DE 8888900179T DE 3785673 T DE3785673 T DE 3785673T DE 3785673 D1 DE3785673 D1 DE 3785673D1
Authority
DE
Germany
Prior art keywords
monoclonal antibody
human
reactivity
cells
peripheral blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888900179T
Other languages
English (en)
Other versions
DE3785673T2 (de
Inventor
James Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Application granted granted Critical
Publication of DE3785673D1 publication Critical patent/DE3785673D1/de
Publication of DE3785673T2 publication Critical patent/DE3785673T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
DE8888900179T 1986-12-08 1987-11-17 Monoklonaler antikoerper spezifisch gegen neutrophilen. Expired - Fee Related DE3785673T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93886486A 1986-12-08 1986-12-08
US07/070,202 US4931395A (en) 1986-12-08 1987-07-06 Monoclonal antibody specific to neutrophils
PCT/US1987/003035 WO1988004320A1 (en) 1986-12-08 1987-11-17 Monoclonal antibody specific to neutrophils

Publications (2)

Publication Number Publication Date
DE3785673D1 true DE3785673D1 (de) 1993-06-03
DE3785673T2 DE3785673T2 (de) 1993-08-19

Family

ID=26750894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888900179T Expired - Fee Related DE3785673T2 (de) 1986-12-08 1987-11-17 Monoklonaler antikoerper spezifisch gegen neutrophilen.

Country Status (14)

Country Link
US (1) US4931395A (de)
EP (1) EP0338003B1 (de)
JP (2) JP2554153B2 (de)
KR (1) KR960013131B1 (de)
CN (1) CN1024285C (de)
AT (1) ATE88751T1 (de)
AU (1) AU611407B2 (de)
CA (1) CA1283066C (de)
DE (1) DE3785673T2 (de)
DK (1) DK440988D0 (de)
IL (1) IL84595A0 (de)
MX (1) MX9203237A (de)
NO (1) NO174855C (de)
WO (1) WO1988004320A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618212B2 (en) * 1987-06-30 1991-12-12 Coulter International Corporation Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils
IE67038B1 (en) * 1988-12-22 1996-02-21 Patrick Joseph Joyce Immunodiagnostic assays for use in the detection and determination of mastitis
US5348859A (en) * 1990-11-23 1994-09-20 Coulter Corporation Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
US5814468A (en) * 1996-03-27 1998-09-29 Coulter International Corp. Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution
US6696243B2 (en) 2001-01-23 2004-02-24 Coulter International Corp. Method for the analysis of soluble analytes
US7608258B2 (en) * 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
WO2005065269A2 (en) * 2003-12-29 2005-07-21 Am Biosolutions Compositions and method for decreasing the appearance of skin wrinkles
US7678780B2 (en) * 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
US20070122906A1 (en) * 2003-12-29 2007-05-31 Allan Mishra Method of culturing cells
US7462268B2 (en) * 2004-08-20 2008-12-09 Allan Mishra Particle/cell separation device and compositions
WO2010042658A1 (en) 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618212B2 (en) * 1987-06-30 1991-12-12 Coulter International Corporation Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils

Also Published As

Publication number Publication date
IL84595A0 (en) 1988-04-29
CN87107275A (zh) 1988-08-17
DE3785673T2 (de) 1993-08-19
MX9203237A (es) 1992-07-01
KR960013131B1 (ko) 1996-09-30
NO883495L (no) 1988-08-05
NO174855B (no) 1994-04-11
JP2554153B2 (ja) 1996-11-13
AU1046088A (en) 1988-06-30
JPH08275775A (ja) 1996-10-22
JP2667140B2 (ja) 1997-10-27
CN1024285C (zh) 1994-04-20
NO174855C (no) 1994-07-20
AU611407B2 (en) 1991-06-13
WO1988004320A1 (en) 1988-06-16
JPH02501029A (ja) 1990-04-12
EP0338003A1 (de) 1989-10-25
DK440988A (da) 1988-08-05
ATE88751T1 (de) 1993-05-15
KR890700161A (ko) 1989-03-10
CA1283066C (en) 1991-04-16
DK440988D0 (da) 1988-08-05
NO883495D0 (no) 1988-08-05
EP0338003A4 (de) 1990-01-26
EP0338003B1 (de) 1993-04-28
US4931395A (en) 1990-06-05

Similar Documents

Publication Publication Date Title
DE3785673T2 (de) Monoklonaler antikoerper spezifisch gegen neutrophilen.
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
ATE94205T1 (de) Monoklonale antikoerper gegen melanoma-assoziierte antigene, hybridzellinien, die diese antikoerper produzieren, und ihre verwendung.
ATE13692T1 (de) Hybridzellinie zur herstellung komplementfixierender monoklonaler antikoerper gegen menschliche suppressor-t-zellen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
KR880006357A (ko) 인터류킨-i에 대한 항체
DE3586440D1 (de) Zur diagnose von menschlichem magen- oder brustkrebs zu verwendender monoklonaler antikoerper.
DE69020007D1 (de) Vernetzte Antikörper und Verfahren zu ihrer Herstellung.
DE68913402T2 (de) Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung.
DE69433378D1 (de) Humane b-lymphoblastoiden zellinie welche anti-gangliosid-antikörper sekretiert
ATE12660T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches thymozytantigen, antikoerper und verfahren zu seiner herstellung, diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
DK392387D0 (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
GB2182949A (en) Monoclonal antibodies and antigens for human non-small cell lung carcinomas
ES547051A0 (es) Procedimiento para obtener complejos fviii-vwf para uso te- rapeutico
DE69030494T2 (de) Karzinomverwandtes haptoglobin (hpr)
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
DE3689868D1 (de) Monoklonale Antikörper gegen menschliches Plasma-Prekallikrein und Verfahren zu ihrer Herstellung und Verwendung.
ES2010761A6 (es) Un procedimiento para obtener una linea celular hibrida productora de un anticuerpo monoclonal especifico de sitio determinante comun de neutrofilos y eosinofilos.
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
ES2008956A6 (es) Un procedimiebto para obtener una linea de celulas hibridas capaces deproducir anticuerpos monoclonales singularmente especificos de los neutrofilos humanos.
JPS6490198A (en) Monoclonal antibody, its production and reagent consisting thereof for detecting virus
KR840005345A (ko) 인체 모노클로날 항체 및 림포킨의 제조 방법
IL73281A0 (en) Purified antigen isolated from sera of leukemia and lymphoma patients,novel antibodies to said antigen,methods of preparing same and diagnostic and therapeutic methods employing said antibody

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee